— Know what they know.
Not Investment Advice
Also trades as: GNS.L (LSE) · $vol 6M

GENSF OTC

Genus plc
1W: +1.5% 1M: -6.9% 3M: -6.9% YTD: -17.3% 1Y: -17.7% 3Y: -15.0% 5Y: -59.5%
$28.95
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 40 · $1.9B mcap · 65M float · 0.0000% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$647M -3.8% ▼
5Y CAGR: +2.4%
Gross Profit
$0 -100.0% ▼
Operating Income
$86M +102.6% ▲
5Y CAGR: +6.9%
Net Income
$281M +1354.4% ▲
5Y CAGR: +42.8%
EPS (Diluted)
$4.19 +1576.0% ▲
5Y CAGR: +42.2%
EBITDA
$126M +34.6% ▲
5Y CAGR: +8.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2026
Revenue$593M$690M$669M$673M$647M
YoY Growth+3.3%+16.2%-3.0%+0.6%-3.8%
Cost of Revenue$367M$450M$490M$0$0
Gross Profit$226M$239M$179M$673M$0
Gross Margin38.1%34.7%26.7%100.0%0.0%
R&D Expenses$73M$93M$28M$0$0
SG&A Expenses$89M$93M$109M$0$0
Operating Expenses$172M-$649M$172M$630M$521M
Operating Income$57M$40M$6M$42M$86M
Operating Margin9.5%5.9%1.0%6.3%13.3%
Interest Expense$6M$14M$21M$20M$16M
Income Before Tax$48M$39M$6M$28M$305M
Tax Expense$12M$17M$3M$0$25M
Net Income$41M$33M$8M$19M$281M
Net Margin6.9%4.8%1.2%2.9%43.4%
EPS (Diluted)$0.62$0.50$0.12$0.25$4.19
EBITDA$80M$88M$74M$94M$126M
Shares Outstanding66M66M66M67M67M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms